BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
It has been a great experience so far, exciting!
Quelles sont les meilleures choses à propos de votre équipe?
It is transparent and we all work well together.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
It is exciting and amazing therapeutics in the pipeline.
Qu’est-ce qui vous rend le plus heureux au travail?
Being part of something new an exciting in the therapeutic area for patients.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
They are clear in their vision and focused on gathering the right talent to move the organization from research to a pre-commercial.
Other Employee Reviews for BlueRock Therapeutics
×